Total Funding
22
33
Total FundingPost-IPO Debt raised
Growth Score
-1 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
183713
BioDelivery Sciences is a pharmaceutical company that focuses on pain management and addiction medicine.
Acquired by 
Collegium Pharmaceutical
Mary Theresa Coelho: Chief Financial Officer, Finance & Chief Accounting Officer, Accounting- Ernest De Paolantonio: Chief Financial Officer
About the Company
BioDelivery Sciences is a pharmaceutical company that focuses on pain management and addiction medicine. They are utilizing their novel and proprietary BioErodible MucoAdhesive (BEMA) drug delivery technology to develop and commercialize, either on their own or in partnership with third parties, new applications of proven therapies aimed at
addressing important unmet medical needs.
